Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
Published Online: 12 DEC 2012
Assessed as up-to-date: 13 JUN 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD006921. DOI: 10.1002/14651858.CD006921.pub3.
- Publication Status: New search for studies and content updated (no change to conclusions)
- Published Online: 12 DEC 2012
This article has been cited by:
- 1Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, The Lancet, 2015,, , , , , , , , , , ,
- 3Tratado de enfermería neurológica, 2013,, ,